Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rocío Herrero-Vanrell

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 3, 2004
Study of gamma-irradiation effects on aciclovir poly(D,L-lactic-co-glycolic) acid microspheres for intravitreal administrationConcepción Martínez-Sancho, Rocío Herrero-Vanrell, Sofía Negro
Clinical Ophthalmology (Auckland, N.Z.)|March 9, 2011
Clinical applications of the sustained-release dexamethasone implant for treatment of macular edemaRocío Herrero-Vanrell, Jose Augusto Cardillo, Baruch D Kuppermann
International Journal of Pharmaceutics|February 24, 2006
Radiosterilisation of indomethacin PLGA/PEG-derivative microspheres: protective effects of low temperature during gamma-irradiationAna Fernández-Carballido, Patricia Puebla, Rocío Herrero-Vanrell, et al.
Experimental Eye Research|April 4, 2009
Downregulation of endotoxin-induced uveitis by intravitreal injection of polylactic-glycolic acid (PLGA) microspheres loaded with dexamethasoneEmilia Barcia, Rocío Herrero-Vanrell, Ana Díez, et al.
Pharmaceutics|March 28, 2024
Useful Role of a New Generation of Dexamethasone, Vitamin E and Human Serum Albumin Microparticles in the Prevention of Excitotoxicity Injury in Retinal Ocular DiseasesJavier Rodríguez Villanueva, Pedro de la Villa, Rocío Herrero-Vanrell, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 19, 2016
Optimising the controlled release of dexamethasone from a new generation of PLGA-based microspheres intended for intravitreal administrationJavier Rodríguez Villanueva, Irene Bravo-Osuna, Rocío Herrero-Vanrell, et al.
Drug Delivery and Translational Research|February 28, 2021
Co-delivery of glial cell-derived neurotrophic factor (GDNF) and tauroursodeoxycholic acid (TUDCA) from PLGA microspheres: potential combination therapy for retinal diseasesAlicia Arranz-Romera, Sergio Esteban-Pérez, Irene T Molina-Martínez, et al.
Current Medicinal Chemistry|September 6, 2019
Trojan Microparticles Potential for Ophthalmic Drug DeliverySergio Esteban-Pérez, Irene Bravo-Osuna, Vanessa Andrés-Guerrero, et al.
Experimental Eye Research|December 6, 2008
Ophthalmic formulations of the intraocular hypotensive melatonin agent 5-MCA-NATVanessa Andrés-Guerrero, Pilar Alarma-Estrany, Irene T Molina-Martínez, et al.
Experimental Eye Research|December 17, 2017
Improved in vitro corneal delivery of a thrombospondin-1-derived peptide using a liposomal formulationLaura Soriano-Romaní, Jesús Álvarez-Trabado, Antonio López-García, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 3, 2004
Study of gamma-irradiation effects on aciclovir poly(D,L-lactic-co-glycolic) acid microspheres for intravitreal administrationConcepción Martínez-Sancho, Rocío Herrero-Vanrell, Sofía Negro
Clinical Ophthalmology (Auckland, N.Z.)|March 9, 2011
Clinical applications of the sustained-release dexamethasone implant for treatment of macular edemaRocío Herrero-Vanrell, Jose Augusto Cardillo, Baruch D Kuppermann
International Journal of Pharmaceutics|February 24, 2006
Radiosterilisation of indomethacin PLGA/PEG-derivative microspheres: protective effects of low temperature during gamma-irradiationAna Fernández-Carballido, Patricia Puebla, Rocío Herrero-Vanrell, et al.
Experimental Eye Research|April 4, 2009
Downregulation of endotoxin-induced uveitis by intravitreal injection of polylactic-glycolic acid (PLGA) microspheres loaded with dexamethasoneEmilia Barcia, Rocío Herrero-Vanrell, Ana Díez, et al.
Pharmaceutics|March 28, 2024
Useful Role of a New Generation of Dexamethasone, Vitamin E and Human Serum Albumin Microparticles in the Prevention of Excitotoxicity Injury in Retinal Ocular DiseasesJavier Rodríguez Villanueva, Pedro de la Villa, Rocío Herrero-Vanrell, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 19, 2016
Optimising the controlled release of dexamethasone from a new generation of PLGA-based microspheres intended for intravitreal administrationJavier Rodríguez Villanueva, Irene Bravo-Osuna, Rocío Herrero-Vanrell, et al.
Drug Delivery and Translational Research|February 28, 2021
Co-delivery of glial cell-derived neurotrophic factor (GDNF) and tauroursodeoxycholic acid (TUDCA) from PLGA microspheres: potential combination therapy for retinal diseasesAlicia Arranz-Romera, Sergio Esteban-Pérez, Irene T Molina-Martínez, et al.
Current Medicinal Chemistry|September 6, 2019
Trojan Microparticles Potential for Ophthalmic Drug DeliverySergio Esteban-Pérez, Irene Bravo-Osuna, Vanessa Andrés-Guerrero, et al.
Experimental Eye Research|December 6, 2008
Ophthalmic formulations of the intraocular hypotensive melatonin agent 5-MCA-NATVanessa Andrés-Guerrero, Pilar Alarma-Estrany, Irene T Molina-Martínez, et al.
Experimental Eye Research|December 17, 2017
Improved in vitro corneal delivery of a thrombospondin-1-derived peptide using a liposomal formulationLaura Soriano-Romaní, Jesús Álvarez-Trabado, Antonio López-García, et al.
Pageof 6